M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon ...

KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat. In ...

This colorized abdominal X-ray shows cancer of the ascending colon; the tumor appears as the oval shadow over the right pelvic bone (left on image). Colorectal cancer is often thought to ...

Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Colon cancer is the disease characterized by the development of malignant cells in the lining or epithelium of the first and longest portion of the large intestine. Acquiring subcellular-level ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

The US Food and Drug Administration (FDA) has announced it has approved colon cancer drug, Zaltrap, for use in combination with a folinic acid, fluorouracil and iriontecan (FOLFIRI) chemotherapy ...

Zinc-Transporting Protein Contributes to Aggressive Growth of Brain Tumor May 1, 2025 — Researchers detail their discoveries about why the brain tumor glioblastoma is so aggressive. Their ...

A panelist discusses how NCCN guidelines now include cabozantinib as a category 1 recommendation for gastrointestinal (GI) neuroendocrine tumors (NETs) after prior treatment with everolimus or ...

Colon dysplasia is typically detected and removed during routine colon cancer screenings. Inflammatory bowel disease (IBD) is a risk factor for developing dysplasia in the colon. Dysplasia doesn ...